• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人药代动力学改变的生物学决定因素。

Biological determinants of altered pharmacokinetics in the elderly.

作者信息

Shand D G

出版信息

Gerontology. 1982;28 Suppl 1:8-17. doi: 10.1159/000212568.

DOI:10.1159/000212568
PMID:7044905
Abstract

The biological determinants of drug disposition have been clearly identified and methods are available to quantify what effects altering them will have on drug kinetics. The factors include blood flow and intrinsic clearance of the organ of elimination, drug binding in blood and tissues, and, in the case of drugs eliminated by the liver, the oral route of administration. The effects of these various factors on drug elimination depend on the efficiency of the elimination process. At one end of the spectrum, some drug elimination is very efficient as it is largely flow-dependent, while at the other elimination depends largely on intrinsic clearance. The oral route of elimination may be important for drugs which undergo efficient hepatic extraction, when a large "first-pass" effect results. In addition, that fraction of the drug escaping first-pass elimination is largely dependent on intrinsic clearance and not flow. Finally, plasma drug binding may affect both elimination and drug distribution. The way in which these factors can be affected by the aging process will be discussed and illustrated with examples showing how changes in organ blood flow, intrinsic clearance and plasma drug binding can produce pharmacokinetic changes seen in the elderly.

摘要

药物处置的生物学决定因素已被明确识别,并且有方法可用于量化改变这些因素对药物动力学的影响。这些因素包括消除器官的血流和内在清除率、药物在血液和组织中的结合,以及对于经肝脏消除的药物而言的口服给药途径。这些不同因素对药物消除的影响取决于消除过程的效率。在一个极端情况下,一些药物消除非常高效,因为它很大程度上依赖于血流,而在另一个极端情况下,消除很大程度上取决于内在清除率。当产生较大的“首过”效应时,口服消除途径对于那些经历高效肝脏提取的药物可能很重要。此外,逃过首过消除的那部分药物很大程度上取决于内在清除率而非血流。最后,血浆药物结合可能会影响消除和药物分布。将讨论这些因素如何受到衰老过程的影响,并举例说明器官血流、内在清除率和血浆药物结合的变化如何导致在老年人中观察到的药代动力学变化。

相似文献

1
Biological determinants of altered pharmacokinetics in the elderly.老年人药代动力学改变的生物学决定因素。
Gerontology. 1982;28 Suppl 1:8-17. doi: 10.1159/000212568.
2
Altered hepatic blood flow and drug disposition.肝脏血流和药物处置的改变。
Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005.
3
Clinical significance of pharmacokinetic models of hepatic elimination.肝脏消除药代动力学模型的临床意义。
Clin Pharmacokinet. 1990 Jan;18(1):61-76. doi: 10.2165/00003088-199018010-00004.
4
Commentary: a physiological approach to hepatic drug clearance.述评:肝脏药物清除的生理学方法
Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377.
5
Comparative pharmacokinetic changes and drug therapy in an older population.老年人群的比较药代动力学变化及药物治疗
J Am Geriatr Soc. 1982 Nov;30(11 Suppl):S11-9. doi: 10.1111/j.1532-5415.1982.tb01351.x.
6
A new model-independent physiological approach to study hepatic drug clearance and its applications.一种用于研究肝脏药物清除率的新型非模型依赖生理学方法及其应用。
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90.
7
Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.有机阴离子转运多肽(OATPs)在药物处置中的临床意义:它们在肝脏清除和肠道吸收中的作用。
Biopharm Drug Dispos. 2013 Jan;34(1):45-78. doi: 10.1002/bdd.1823.
8
Pharmacokinetics in the elderly.老年人的药代动力学。
Clin Pharmacokinet. 1976;1(4):280-96. doi: 10.2165/00003088-197601040-00003.
9
Hepatic disease and drug pharmacokinetics.肝脏疾病与药物药代动力学
Clin Pharmacokinet. 1980 Nov-Dec;5(6):528-47. doi: 10.2165/00003088-198005060-00002.
10
Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged.药物治疗中的药代动力学。VII:影响老年人药物治疗的药代动力学因素。
Am J Hosp Pharm. 1980 Apr;37(4):559-62.

引用本文的文献

1
[Pharmacological peculiarities and problems with older patients].[老年患者的药理学特点及问题]
Anaesthesist. 2005 May;54(5):467-75. doi: 10.1007/s00101-005-0810-9.
2
Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients.喜得镇新口服制剂在老年患者中的稳态生物利用度。
Eur J Clin Pharmacol. 1984;26(1):133-5. doi: 10.1007/BF00546722.
3
Effect of age and sex on the plasma binding of acidic and basic drugs.年龄和性别对酸性及碱性药物血浆蛋白结合率的影响。
Eur J Clin Pharmacol. 1984;27(1):91-7.
4
Pharmacokinetics of aztreonam in patients with gram-negative infections.氨曲南在革兰氏阴性菌感染患者中的药代动力学。
Antimicrob Agents Chemother. 1985 Jan;27(1):16-20. doi: 10.1128/AAC.27.1.16.
5
Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults.吡罗昔康在老年人与年轻人中的单剂量及稳态药代动力学
Eur J Clin Pharmacol. 1985;28(3):305-9. doi: 10.1007/BF00543328.
6
Pharmacokinetics of ceftazidime in elderly volunteers.头孢他啶在老年志愿者中的药代动力学。
Antimicrob Agents Chemother. 1985 Nov;28(5):713-5. doi: 10.1128/AAC.28.5.713.
7
Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients.急性病老年患者静脉注射抗生素的药代动力学
Eur J Clin Microbiol. 1986 Dec;5(6):629-33. doi: 10.1007/BF02013286.
8
Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.头孢哌酮在老年门诊志愿者与年轻成年人中的药代动力学比较。
Antimicrob Agents Chemother. 1987 Jun;31(6):925-9. doi: 10.1128/AAC.31.6.925.
9
Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activity.老年室性异位活动患者中酒石酸丙基阿马林的药代动力学
Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar;12(1):77-82. doi: 10.1007/BF03189865.
10
Effect of age and renal function on cefonicid pharmacokinetics.年龄和肾功能对头孢尼西药代动力学的影响。
Antimicrob Agents Chemother. 1989 Feb;33(2):142-6. doi: 10.1128/AAC.33.2.142.